Royal Bank Of Canada Geo Vax Labs, Inc. Transaction History

Royal Bank Of Canada

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.55 - $17.1 $14 - $461	-27 Reduced 35.06%	50 $0
Q3 2022 Nov 14, 2022	BUY	$0.4 - $58.5 $10 - $1,579	27 Added 54.0%	77 $0
Q2 2022 Aug 15, 2022	BUY	$9.29 - $34.8 $464 - $1,739	50 New	50 $0

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.